1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Health economic evaluation of the Lund Integrated Medicines Management Model (LIMM) in elderly patients admitted to hospital.
(
- Contribution to journal › Article
-
Mark
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature.
(
- Contribution to journal › Article
-
Mark
A Candidate Gene Approach to ANCA-Associated Vasculitis Reveals Links to the C3 and CTLA-4 Genes but not to the IL1-Ra And Fcγ-RIIa Genes.
(
- Contribution to journal › Article
- 2012
-
Mark
Societal Value of Stem Cell Therapy in Stroke - A Modeling Study.
(
- Contribution to journal › Article
- 2007
-
Mark
Cost-effectiveness analysis of treatment with epoietin-alpha for patients with anaemia due to renal failure: The case of Sweden.
(
- Contribution to journal › Article
- 2006
-
Mark
En blodtransfusion i Sverige - så mycket kostar den samhället
(
- Contribution to journal › Article
-
Mark
Comparative cost-effectiveness of anticoagulation with bivalirudin or heparin with and without a glycoprotein IIb/IIIa-receptor inhibitor in patients undergoing percutaneous coronary intervention in Sweden: a decision-analytic model.
(
- Contribution to journal › Article
- 2005
-
Mark
Screening for congenital cataracts: A cost-consequence analysis of eye examination at maternity wards in comparison to well-baby clinics
(
- Contribution to journal › Article
-
Mark
Alport syndrome caused by inversion of a 21 Mb fragment of the long arm of the X-chromosome comprising exon 9 through 51 of the COL4A5 gene
(
- Contribution to journal › Article
-
Mark
Alport syndrome in southern Sweden.
(
- Contribution to journal › Article